"[Buprenorphine] is a tremendously powerful medication, saves many lives and prevents overdose, but there is a risk of misuse and diversion, albeit pretty low," says Dr. Francis Levin.
“Our findings open the door for the development of treatments to target specific symptoms of psychosis depending on an individual subject’s symptom profile," says Guillermo Horga, MD, PhD
“For some people, this illness is highly disabling, but there’s a significant number of people who have this illness who are able to live very fulfilling lives,” said Dr. Lisa Dixon.
"Our results highlight the critical need to improve buprenorphine treatment services, especially for the youngest with opioid use disorder," Dr. Mark Olfson said.
"Our results highlight the critical need to improve buprenorphine treatment services, especially for the youngest with opioid use disorder," Dr. Mark Olfson said.
Researchers at Columbia University used magnetic resonance imaging (MRI) to understand brain structural alterations in children and adolescents with OCD that predict psychotherapy treatment response.
In an accompanying editorial, Dr. Joshua T. Kantrowitz explained how the future role of lumateperone could be crucial in treating schizophrenia patients.
Dr. Michael Grunebaum says that in his clinical trials, many patients don’t find that the drug relieves anxiety. “Ketamine is just a really distinct, weird, spacey feeling,” he says.
A discussion with Dr. Deborah Cabaniss and Dr. Yael Holoshitz about their new book Different Patients, Different Therapies: Optimizing Treatment Using Differential Psychotherapuetics.